Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Omics research in diabetic kidney disease: new biomarker dimensions and new understandings?

30 May 2020

Abstract excerpt

The use of "omics" is increasing in research areas looking to identify biomarkers or early preclinical signs of disease or to increase understanding of complex pathological processes that determines prognosis of the disease. Diabetic kidney disease is no exception as it is an area in need of further improvement of both understanding and prognosis. In addition, there is a notion that pretreatment investigations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Treatment and Management
Share to Diet and metabolism studies
Share to Pancreatic function and diabetes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32474762
DOI: 10.1007/s40620-020-00759-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Omics research in diabetic kidney disease: new biomarker dimensions and new understandings?PMID 32474762Read ↗

Urine Proteomics Identifies Biomarkers for Diabetic Kidney Disease at Different StagesSemantic proximity Read ↗

Biomarkers of Diabetic Nephropathy, the Present and the FutureSemantic proximity Read ↗

Metabolomics and Proteomics in Type 2 DiabetesSemantic proximity Read ↗

Insights into Diabetic Kidney Disease Using Urinary Proteomics and BioinformaticsSemantic proximity Read ↗

Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine.Semantic proximity Read ↗

Perspectives on systems biology applications in diabetic kidney disease.Semantic proximity Read ↗

Emerging applications of metabolomic and genomic profiling in diabetic clinical medicine.Semantic proximity Read ↗

Metabolomics in Adult and Pediatric NephrologySemantic proximity Read ↗

Discovering a trans-omics biomarker signature that predisposes high risk diabetic patients to diabetic kidney diseaseSemantic proximity Read ↗

Metabolomics and renal disease.Semantic proximity Read ↗

New insights into the role of immunity and inflammation in diabetic kidney disease in the omics eraSemantic proximity Read ↗

Insights into the Novel Biomarkers Expressed in Diabetic Nephropathy: Potential Clinical ApplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.